Additionally, SGLT2 protein qualitative expression was evaluated by Western blot in osteoblast-like cell lysates and by immunohistochemistry in bone samples from apparently healthy individuals and patients with CKD. This evidence concerns the gene SLC5A2 and chronic kidney disease.